The CRO concept continued to rise in the intraday market. Nanmo Biotech rose and stopped 20 cm. Previously, Broji Pharmaceuticals rose 20 cm, Wanbang Pharmaceutical rose 18%, and nearshore protein, Haoyuan Pharmaceuticals, Wisdom Pharmaceuticals, Opumai, and Bioosetu registered higher gains.

Zhitongcaijing · 2d ago
The CRO concept continued to rise in the intraday market. Nanmo Biotech rose and stopped 20 cm. Previously, Broji Pharmaceuticals rose 20 cm, Wanbang Pharmaceutical rose 18%, and nearshore protein, Haoyuan Pharmaceuticals, Wisdom Pharmaceuticals, Opumai, and Bioosetu registered higher gains.